Market Place
Sourcing Support
Novartis Scores Double Phase 3 Win in Sjögren`s Syndrome
12 Aug 2025 //
FIERCE BIOTECH
Novartis Weighs Deal for Biotech Avidity Biosciences
09 Aug 2025 //
REUTERS
FDA Approves Novartis` Leqvio (Inclisiran) for First-Line Use
31 Jul 2025 //
PR NEWSWIRE
Novartis India Reports Rs. 27.62 Cr Net Profit in Q1 FY26
30 Jul 2025 //
INDPHARMAPOST
Novartis Drops up to $1B+ for Drug Discovery Deal With Matchpoint
26 Jul 2025 //
GLOBENEWSWIRE
Analysis Group Explores HEOR Use in Rare Disease CGTs
22 Jul 2025 //
PR NEWSWIRE
Novartis Speeds up Us Manufacturing of Key Drugs as Tariffs
18 Jul 2025 //
BIOSPACE
Novartis` Pluvicto Picks up Speed, Delivers Another Trial Win
17 Jul 2025 //
FIERCE PHARMA
Novartis boosts FY 2025 core income outlook on robust Q2 sales
17 Jul 2025 //
GLOBENEWSWIRE
Novartis Names Mukul Mehta CFO as Harry Kirsch Retires
17 Jul 2025 //
GLOBENEWSWIRE
Novartis Loses Bid to Block Us Entresto Generic Through 2026
14 Jul 2025 //
REUTERS
US Entresto Generic Unblocked as Novartis Loses Bid till 2026
11 Jul 2025 //
REUTERS
Novartis inks $175M option deal for Sironax’s blood-brain barrier
10 Jul 2025 //
PR NEWSWIRE
Novartis` Malaria Drug for Babies Gets First Global Approval
08 Jul 2025 //
FIERCE PHARMA
Novartis gets Approval for First malaria drug for babies
08 Jul 2025 //
REUTERS
Novartis Drug Cosentyx Fails Late-Stage Trial for Artery Disease
05 Jul 2025 //
REUTERS
Novartis Pens ProFound Pact for Cardiovascular Disease Targets
27 Jun 2025 //
FIERCE BIOTECH
Novartis completes acquisition of Regulus Therapeutics
25 Jun 2025 //
GLOBENEWSWIRE
Amneal, Kashiv Report Positive Data for Xolair Biosimilar
25 Jun 2025 //
GLOBENEWSWIRE
Novartis HSR waiting period for Regulus Therapeutics offer ends
23 Jun 2025 //
GLOBENEWSWIRE
Biogen, BMS and Novartis bag spots on Cannes Lions shortlists
16 Jun 2025 //
FIERCE PHARMA
Novartis Fabhalta® improves hemoglobin in new PNH patients
12 Jun 2025 //
GLOBENEWSWIRE
Novartis Asks Court for Swift Decision in Entresto Patent Case
07 Jun 2025 //
FIERCE PHARMA
Novartis` Pluvicto to Slow Prostate Cancer in Earlier Setting
03 Jun 2025 //
REUTERS
Novartis Pluvicto Shows rPFS Benefit In PSMA+ Prostate Cancer
02 Jun 2025 //
GLOBENEWSWIRE
Novartis Kisqali Cut Recurrence Risk in Young Early Breast Cancer
01 Jun 2025 //
GLOBENEWSWIRE
Novartis expands collaboration with Shanghai Pharma in China
27 May 2025 //
FIERCE PHARMA
5 People Accused of Insider Trading Tied to Novartis Buy
27 May 2025 //
FIERCE BIOTECH
Novartis starts tender offer for Regulus Therapeutics
27 May 2025 //
GLOBENEWSWIRE
Apotex Launches Generic Tasigna Capsules in Us with Exclusivity
27 May 2025 //
PR NEWSWIRE
Novartis Offers Payment Plan for High-Cost Heart Medicine
27 May 2025 //
ECONOMICTIMES
Novartis data at ASCO and EHA highlights Momentum of Portfolio
15 May 2025 //
GLOBENEWSWIRE
Abu Dhabi, Novartis Ink Deal for Disease Prevention
14 May 2025 //
BIOSPECTRUM
Erasca looks to partner off late-stage melanoma asset
14 May 2025 //
FIERCE BIOTECH
Novartis to keep making malaria drugs if orders dry up amid cuts
12 May 2025 //
REUTERS
PTC and Novartis’ Huntington`s data fail to convince investors
07 May 2025 //
FIERCE BIOTECH
Incyte, Novartis reach settlement in Jakafi royalty dispute
06 May 2025 //
FIERCE PHARMA
BioNTech says Novartis executive Zapata to become CFO
05 May 2025 //
REUTERS
Novartis to buy Regulus in up to $1.7 Billion deal
01 May 2025 //
REUTERS
Novartis axes osteoarthritis asset and radioligand therapy
29 Apr 2025 //
FIERCE BIOTECH
Novartis builds momentum with new drug launches
29 Apr 2025 //
FIERCE PHARMA
Novartis raises 2025 forecast on strong Q1 momentum
29 Apr 2025 //
REUTERS
Novartis sees double-digit sales growth, margin expansion in Q1
28 Apr 2025 //
GLOBENEWSWIRE
Novartis & Sanofi CEOs say EU should raise drug prices of tariffs
23 Apr 2025 //
REUTERS
Novartis terminates Ph 2 osteoarthritis trial testing
17 Apr 2025 //
FIERCE BIOTECH
Novartis unveils $23B investment to beef up US manufacturing
12 Apr 2025 //
PR NEWSWIRE
Blackstone & Anthos Announce Novartis has Completed Acquisition
03 Apr 2025 //
BUSINESSWIRE
Novartis receives FDA accelerated approval for Vanrafia
03 Apr 2025 //
PR NEWSWIRE
Grove AI Adds Former Executives to Advisory Board
02 Apr 2025 //
GLOBENEWSWIRE
Market volatility halts Novartis` India arm stake sale
01 Apr 2025 //
#N/A
Novartis appoints Karen Hale as Chief Legal Officer; Klaus Moosma
31 Mar 2025 //
GLOBENEWSWIRE
FDA approve Novartis therapy Pluvicto for earlier use in Prostate Cancer
28 Mar 2025 //
GLOBENEWSWIRE
Novartis to present new data at AAN on Kesimpta® safety in MS.
25 Mar 2025 //
GLOBENEWSWIRE
Novartis receives third FDA approval for oral Fabhalta
21 Mar 2025 //
GLOBENEWSWIRE
Novartis’ Intrathecal Zolgensma Effective in Older Children
20 Mar 2025 //
BIOSPACE
Novartis & Roche ditch some diversity programmes on US concerns
20 Mar 2025 //
REUTERS
Novartis Ph 3 Data Shows Efficacy Of onasemnogene abeparvovec In SMA
19 Mar 2025 //
GLOBENEWSWIRE
Novartis is watching US reciprocal tariff policy `very carefully`
17 Mar 2025 //
REUTERS
Novartis and Folia Health Partner on App-Based IgA Nephropathy Study
13 Mar 2025 //
GLOBENEWSWIRE
Novartis named first corporate pharma partner of Football League
13 Mar 2025 //
PR NEWSWIRE
